We are live on ! Find out more
CTV.WS

Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share

Delisted

CTV.WS was delisted on the 12th of February, 2025.

14 hedge funds and large institutions have $25.7K invested in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% less funds holding

Funds holding: 1614 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

76% less capital invested

Capital invested by funds: $109K → $25.7K (-$83.2K)

Holders
14
Holders Change
-2
Holders Change %
-12.5%
% of All Funds
0.2%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
Closed
3
Calls
$214K
Puts
Net Calls
+$214K
Net Calls Change
+$34K

Top Buyers

Rank Fund Capital Flow
1
CAC
Cowen and Company
New York
+$460

CTV.WS Hedge Fund Activity: Q3 2024 in Review

14 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) for Q3 2024, worth a combined $25.7K — down 76% from $109K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of CTV.WS and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was Cowen and Company, opening a new position worth an estimated $460. The largest seller was LMR Partners, exiting entirely with an estimated $41.2K sold.

  • 14 institutional investors held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) as of Q3 2024, down from 16 in Q2 2024.
  • Funds reported $25.7K of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share stock for Q3 2024, down 76% quarter-over-quarter.
  • 1 fund opened new Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share positions in Q3 2024 and 3 closed out, a net change of -2 holders.
  • The largest Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share buyer in Q3 2024 was Cowen and Company, an estimated $460 added.
  • The largest Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share seller in Q3 2024 was LMR Partners, an estimated $41.2K sold.

Based on aggregated 13F filings for Q3 2024.